Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership20,194 shares
Latest Disclosed Value $ 471
Amalgamated Bank reports 0.96% decrease in ownership of INVA / Innoviva, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 20,194 shares of Innoviva, Inc. (US:INVA) valued at $470,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 20,390 shares of Innoviva, Inc.. The current value of the position is $438,210 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F INNOVIVA COM 45781M101 20,194 -196 -0.96 0 0.0036
2026-02-05 2025-12-31 13F INNOVIVA COM 45781M101 20,390 3,064 17.68 0 0.0029
2025-10-29 2025-09-30 13F INNOVIVA COM 45781M101 17,326 1,494 9.44 0 0.0023
2025-08-04 2025-06-30 13F INNOVIVA COM 45781M101 15,832 0 0.00 0 0.0025
2025-04-25 2025-03-31 13F INNOVIVA COM 45781M101 15,832 -423 -2.60 0 0.0025
2025-02-04 2024-12-31 13F INNOVIVA COM 45781M101 16,255 -147 -0.90 0 0.0023
2024-10-30 2024-09-30 13F INNOVIVA COM 45781M101 16,402 -455 -2.70 0 0.0026
2024-08-12 2024-06-30 13F INNOVIVA COM 45781M101 16,857 -1,436 -7.85 0 0.0024
2024-04-23 2024-03-31 13F INNOVIVA COM 45781M101 18,293 16,681 1,034.80 0 0.0024
2024-02-06 2023-12-31 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,612 -184 -10.24 0 0.0001
2024-02-06 2023-12-31 13F INNOVIVA COM 45781M101 20,927 -2,226 0 0.0027
2023-11-08 2023-09-30 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,796 0 0.00 0 0.0000
2023-11-08 2023-09-30 13F INNOVIVA COM 45781M101 23,153 -1,250 0 0.0026
2023-08-11 2023-06-30 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,796 0 0.00 0 0.0001
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 24,403 -4,188 0 0.0025
2023-05-02 2023-03-31 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,796 -105 -5.52 0 0.0001
2023-05-02 2023-03-31 13F INNOVIVA COM 45781M101 28,591 -1,935 0 0.0027
2023-02-10 2022-12-31 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,901 0 0.00 0 -100.00 0.0001
2023-02-10 2022-12-31 13F INNOVIVA COM 45781M101 30,526 0 0 0.0036
2022-11-09 2022-09-30 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,901 0 0.00 11 0.00 0.0001
2022-11-09 2022-09-30 13F INNOVIVA COM 45781M101 30,526 279 354 0.0034
2022-08-15 2022-06-30 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,901 231 13.83 11 -42.11 0.0001
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 30,247 4,224 446 0.0042
2022-08-25 2022-03-31 13F/A-1 THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,670 -25,704 -93.90 19 -95.97 0.0001
2022-08-25 2022-03-31 13F/A-1 INNOVIVA COM 45781M101 26,023 -1,351 504 0.0039
2022-06-30 2022-03-31 13F THESEUS PHARMACEUTICALS INC COM COM 88369M101 1,670 1,670 19 0.0002
2022-06-30 2022-03-31 13F INNOVIVA COM 45781M101 26,023 -1,351 504 0.0040
2022-02-15 2021-12-31 13F/A-1 INNOVIVA COM 45781M101 27,374 -1,292 -4.51 472 -1.46 0.0035
2022-02-15 2021-12-31 13F INNOVIVA COM 45781M101 27,374 -1,292 472 0.0035
2021-10-29 2021-09-30 13F INNOVIVA COM 45781M101 28,666 -2,805 -8.91 479 13.51 0.0040
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 31,471 31,471 422 0.0034
2021-05-13 2021-03-31 13F INNOVIVA COM 45781M101 0 -10,468 -100.00 0 -100.00
2021-02-12 2020-12-31 13F INNOVIVA COM 45781M101 10,468 68 0.65 130 19.27 0.0049
2020-10-30 2020-09-30 13F INNOVIVA COM 45781M101 10,400 -336 -3.13 109 -27.33 0.0047
2020-08-10 2020-06-30 13F INNOVIVA COM 45781M101 10,736 -1,214 -10.16 150 6.38 0.0069
2020-05-13 2020-03-31 13F INNOVIVA COM 45781M101 11,950 -456 -3.68 141 -19.89 0.0034
2020-02-13 2019-12-31 13F INNOVIVA COM 45781M101 12,406 473 3.96 176 39.68 0.0032
2019-11-13 2019-09-30 13F INNOVIVA COM 45781M101 11,933 -116 -0.96 126 -28.00 0.0026
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 12,049 566 4.93 175 8.70 0.0041
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 11,483 356 3.20 161 -17.01 0.0039
2019-02-15 2018-12-31 13F INNOVIVA COM 45781M101 11,127 11,127 -3.10 194 20.50 0.0055
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 0 -11,267 -100.00 0 -100.00
2018-07-18 2018-06-30 13F INNOVIVA COM 45781M101 11,267 509 4.73 155 -13.41 0.0038
2018-05-22 2018-03-31 13F INNOVIVA COM 45781M101 10,758 -145 -1.33 179 15.48 0.0047
2018-02-13 2017-12-31 13F INNOVIVA COM 45781M101 10,903 519 5.00 155 5.44 0.0042
2017-11-09 2017-09-30 13F INNOVIVA COM 45781M101 10,384 -132 -1.26 147 8.89 0.0046
2017-08-10 2017-06-30 13F INNOVIVA COM 45781M101 10,516 -168 -1.57 135 -8.78 0.0044
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 10,684 -13 -0.12 148 29.82 0.0074
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 10,697 10,697 114 0.0052
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 0 -7,648 -100.00 0 -100.00
2014-08-11 2014-06-30 13F THERAVANCE COM 88338T104 7,648 -1,234 -13.89 228 -17.09 0.0344
2014-05-12 2014-03-31 13F THERAVANCE COM 88338T104 8,882 -68 -0.76 275 -13.79 0.0474
2014-02-13 2013-12-31 13F THERAVANCE COM 88338T104 8,950 8,950 319 0.0542
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.